1 Revista Brasileira de Hematologia e Hemoterapia 2002 Vol: 24(1):. DOI: 10.1590/S1516-84842002000100003

Transplante de células tronco hematopoéticas para doenças auto-imunes no Brasil

Hematopoietic Stem Cell Transplantation presents a solid basis to be indicated for the treatment of autoimmune diseases. In this work data related to the procedure and the sequence of events which have contributed to the implantation of a Brazilian protocol are discussed. Included is a discussion of the autogenic procedure using uniform mobilization regimens with Cyclophosphamide 2g/m2 plus granulocyte-colony stimulation factor and particular conditioning for systemic lupus erythematosus, systemic sclerosis and multiple sclerosis. The formerly described entities were chosen for the beginning of a cooperative protocol after wide-ranging debates which took place both in Ribeirão Preto and San Francisco, USA.

  1. Marmont AM. New horizons in the treatment of severe autoimmune diseases: immunoablation and stem cell transplantation. Ann Rev Med. 2000 51, 115-134 .
  2. Tyndall A, Passweg J, Gratwohl A. Hematopoietic stem cell transplantation in the treatment of severe autoimmune diseases. Ann Rheum Dis 2001. 60 , 702-707 (2000) .
  3. Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure? Blood. 2002 99, 768-784 .
  4. Tamm M, Gratwohl A, Tichelli A, Perruchoud AP, Tyndall A. Autologous hematopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. Ann Rheum Dis 1996 55, 779-780 .
  5. Pasquini R. Transplante de medula óssea em anemias aplásticas. Medicina-Ribeirão Preto. 2000 33, 219-231 .
  6. Ferreira E, Ribeiro A, Bacal N, Takatu T, Rosenblit J, Montezuma MP, Pasternak J, Kufner JM, Rosenfeld LG, Sterling L, Hamerschlak M. Transplante de células tronco periféricas autólogas no tratamento de doença autoimune: remissão completa de anemia hemolítica por aglutinina a frio e concomitante vasculite. Bol Soc Bras Hematol Hemoter. 1996, 18 (supl) , 191-0 .
  7. Voltarelli JC e Stracieri AB. Aspectos imunológicos dos transplantes de células-tronco hematopoéticas. Medicina-Ribeirão Preto. 33 , 443-462 (2000) .
  8. Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, Mujais S, Baker S, Burt RK. Treatment of severe systemic lupus erythematosus with high-dose therapy and hematopoietic stem cell transplantation: a phase I study. Lancet. 356: 701 , (2000) .
  9. Slavin S. Treatment of intractable multiple sclerosis by re-induction of self tolerance in conjunction with autologous stem cell therapy. Protocol proposal , (1997) .
  10. Anderlini P, Giralt S, Andersson B et al. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin’s disease. Bone Marrow Transplant. 26 , 615-620 (2000) .
  11. Comi G, Kappos L, Clanet M et al. Guidelines for autologous and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of European Group for Blood and MarrowTransplantation and the European Charcot Foundation. J Neurol. 247 , 376-382 (2000) .